Craif - About the company
Craif is a series D company based in Tokyo (Japan), founded in 2018 by Ryuichi Onose and Takao Yasui. It operates as a Developer of a device for cancer detection. Craif has raised $89.2M in funding from investors like ANRI, JST and Mori Trust. The company has 753 active competitors, including 225 funded and 166 that have exited. Its top competitors include companies like Guardant Health, Natera and Foundation Medicine.
Company Details
Developer of a device for cancer detection. The company has developed a novel device that is used to collect and separate the microRNA secreted from cancer cells present in the urine. The device uses a combination of zinc oxide nanostructures and microflow channel technologies for the process and early cancer detection.
Key Metrics
Founded Year
2018
Location
Tokyo, Japan
Stage
Series D
Total Funding
$89.2M in 9 rounds
Latest Funding Round
Ranked
34th among 753 active competitors
Employee Count
55 as on Aug 31, 2026
Similar Companies
Sign up to download Craif's company profile
Craif's funding and investors
Craif has raised a total funding of $89.2M over 9 rounds. Its first funding round was on Feb 15, 2019. Its latest funding round was a Series D round on Aug 18, 2026 for $*****. 5 investors participated in its latest round. Craif has 29 institutional investors.
Here is the list of recent funding rounds of Craif:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 18, 2026 | 4752685 | Series D | 5548775 | 7515833 | 6785385 | 8846563 |
Aug 18, 2026 | 8969781 | Conventional Debt | 5133407 | 8337180 | 3112979 | |
Apr 28, 2025 | 7113551 | Series C | 7222202 | 3808929 | 6228760 |
Access funding benchmarks and valuations. Sign up today!View details of Craif's funding rounds and investors
Craif's founders and board of directors
Founder? Claim ProfileHere are the details of Craif's key team members:
- Ryuichi Onose: Co-Founder & CEO of Craif and founder of 1 other company. Contact Info: 2 email addresses
- Takao Yasui: Co-Founder of Craif and founder of 1 other company. Contact Info: 1 email address
View details of Craif's Founder profiles and Board Members
Craif's employee count trend
Craif has 55 employees as of Aug 26. Here is Craif's employee count trend over the years:
Uncover Craif's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Craif's Competitors and alternates
Top competitors of Craif include Guardant Health, Natera and Foundation Medicine. Here is the list of Top 10 competitors of Craif, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Guardant Health 2012, Redwood City (United States), Public | Developer of digital sequencing technology for cancer detection | $557M | 79/100 | |
2nd | Natera 2004, Redwood City (United States), Public | Developer of cell-free DNA testing for oncology, women’s health, and organ health | $152M | 80/100 | |
3rd | Foundation Medicine 2010, Cambridge (United States), Acquired | Provider of genomics-based diagnostics test for cancer | $96.5M | 70/100 | |
4th | Online platform for genetic and diagnostic health testing that helps identify health risks | $67.6M | 69/100 | ||
5th | BillionToOne 2015, San Francisco (United States), Public | Provider of cell-free cancer liquid biopsy test | $389M | 69/100 | |
6th | Myriad Genetics 1991, United States, Public | Developer of molecular diagnostics and personalized medicine for cancer | - | 68/100 | |
7th | Geneoscopy 2015, St. Louis (United States), Series C | Developer of non-invasive biomarker tests for colorectal cancer | $219M | 67/100 | |
8th | Provider of precision oncology solutions, including genomic testing and digital health | $25.9M | 67/100 | ||
9th | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 66/100 | |
10th | Intellia Therapeutics 2014, Cambridge (United States), Public | Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases | $85M | 66/100 | |
34th | Developer of a device for cancer detection | $89.2M | 58/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Craif's competitors? Click here to see the top ones
Craif's Investments and acquisitions
Craif has made no investments or acquisitions yet.
Reports related to Craif
Here is the latest report on Craif's sector:
News related to Craif
Media has covered Craif for 1 event in last 1 year.
•
Craif Secures $33M for AI-Powered Urine Oncology Diagnostics in the USHIT Consultant•Aug 18, 2026•Craif, Unreasonable, TAUNS Laboratories, Granite Asia
•
Craif raises funds in Series C extension round for its "MySignal®" cancer testStartup Log•Jun 11, 2025•Nagase, Craif, Weing
•
Early cancer detection startup Craif raises $22MBEAMSTART•Apr 27, 2025•Craif, X&, Unreasonable, TAUNS Laboratories and 2 others
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Craif
Explore our recently published companies
- Beth Panitz - Unfunded company
- Synergy EV - Georgia based, Unfunded company
- St Joseph's Indian High School - India based, 1904 founded, Unfunded company
- New Mind - Raleigh based, 2010 founded, Unfunded company
- Apex Financial - United States based, 2010 founded, Unfunded company
- IDMED - Marseille based, 2008 founded, Unfunded company
